Repligen

RGEN

Forecast & Rating22 analysts currently cover Repligen, with about 81.8% giving a positive rating — meaning they expect the stock to rise. The average price target is $201.45, about 13.9% upside from the current price of $176.93. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 46.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Repligen closely still see room for the stock to rise. Data as of Oct 23, 2026; for reference only and not investment advice.

Oct 23, 2026
Price forecast
$201.4513.86%
Forecast & RatingBuy
22analysts
  • Strong buy68.18%
  • Buy13.64%
  • Hold18.18%
  • Sell0.00%
  • Strong sell0.00%

Target price forecast

Forecast dateOct 19, 2026
Forecast met46.2%
Stock price$176.93
Avg. target$198.0
High target$235
Low target$145
18-month Forecast11/01/202110/19/2026

Analyst ratings

Strong buy
Buy
Hold
Sell
Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.